Kite Pharma, Inc. 3 SEC Filings

Filed On	Filing
16 Mar 2017	Form 3: Witte Owen N., Director Holds 81,650 shares of Common Stock
05 Jan 2017	Form 3: Clark Ian T, Director No securities owned
18 May 2016	Form 3: Jenkinson Paul L, Chief Financial Officer No securities owned
16 Mar 2016	Form 3: Moore Timothy L., EVP, Technical Operations No securities owned
21 Dec 2015	Form 3: Tomasello Shawn, Chief Commercial Officer Holds 10,000 shares of Common Stock
17 Sep 2015	Form 3: Humer Franz B, Director No securities owned
23 Apr 2015	Form 3: Kim Helen Susan, EVP, Business Development
19 Jun 2014	Form 3: Wiezorek Jeffrey, VP Clinical Development
19 Jun 2014	Form 3: Sproule Rizwana F, VP Regulatory Affairs
19 Jun 2014	Form 3: Ruchefsky Steven B, Director
19 Jun 2014	Form 3: Roberts Margo R, Chief Scientific Officer
19 Jun 2014	Form 3: Peacock Jonathan M, Director
19 Jun 2014	Form 3: Nussbaum Ran, Director
19 Jun 2014	Form 3: Kazam Joshua A, Director Holds 437,500 shares of Common Stock
19 Jun 2014	Form 3: Doumani Roy, Director
19 Jun 2014	Form 3: Chang David D, EVP, R&D, Chief Medical Off.
19 Jun 2014	Form 3: Champsi Farah, Director
19 Jun 2014	Form 3: Butitta Cynthia M, COO and CFO Holds 72,566 shares of Common Stock
19 Jun 2014	Form 3: Bonderman David, Director
19 Jun 2014	Form 3: Better Marc, VP, Product Sciences

Comments